Sanofi SA (FRA:SNW)
€ 92.33 -1.89 (-2.01%) Market Cap: 115.85 Bil Enterprise Value: 125.29 Bil PE Ratio: 21.94 PB Ratio: 1.59 GF Score: 81/100

Sanofi SA at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 12:20PM GMT
Release Date Price: €87.8 (-0.01%)
Operator

This presentation is for Bank of America clients only. If you are a member of the media or the press, please disconnect now.

Graham Glyn Charles Parry
BofA Merrill Lynch, Research Division - MD and Head of Healthcare Equity Research

Okay. Welcome, everybody, and thanks for joining us this afternoon for our next company session, which is Sanofi. From Sanofi, I'm very pleased to be able to introduce Paul Hudson, CEO; and Jean-Baptiste de Chatillon, the CFO of the company. Both are in the same room together, which is convenient in this day and age.

Questions & Answers

Graham Glyn Charles Parry;Paul Hudson
BofA Merrill Lynch, Research Division - MD and Head of Healthcare Equity Research;Sanofi - CEO &

And so I'd perhaps like to kick off with an open question for Paul. You're just over a year into the role now. So perhaps if you could just give us a brief recap on what you think you've achieved in the last 12 months and what your priorities for the next 12 months are.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot